Cargando…
Alteration of plasma metabolites associated with chemoradiosensitivity in esophageal squamous cell carcinoma via untargeted metabolomics approach
BACKGROUND: To investigate the differences in plasma metabolomic characteristics between pathological complete response (pCR) and non-pCR patients and identify biomarker candidates for predicting the response to neoadjuvant chemoradiotherapy (nCRT) in esophageal squamous cell carcinoma (ESCC). METHO...
Autores principales: | Zhang, Yaowen, Wang, Jianpo, Dai, Ningtao, Han, Peng, Li, Jian, Zhao, Jiangman, Yuan, Weilan, Zhou, Jiahuan, Zhou, Fuyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466788/ https://www.ncbi.nlm.nih.gov/pubmed/32878621 http://dx.doi.org/10.1186/s12885-020-07336-9 |
Ejemplares similares
-
Low RCAN1.2 mRNA Expression Is Associated with Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma
por: Yang, Haijun, et al.
Publicado: (2023) -
hsa_circRNA6448-14 promotes carcinogenesis in esophageal squamous cell carcinoma
por: Zhang, Yaowen, et al.
Publicado: (2020) -
Correction for: hsa_circRNA6448-14 promotes carcinogenesis in esophageal squamous cell carcinoma
por: Zhang, Yaowen, et al.
Publicado: (2020) -
Untargeted metabolomics analysis of esophageal squamous cell cancer progression
por: Yang, Tao, et al.
Publicado: (2022) -
The molecular basis of chemoradiosensitivity in rectal cancer:implications for personalized therapies
por: Grade, Marian, et al.
Publicado: (2012)